Acta Scientific Medical Sciences (ISSN: 2582-0931)

Research Article Volume 4 Issue 2

HIV and HTLV Co-Infection in Abang Minko’o Area of the South Region of Cameroon

Fonweban Yvonne Ngoikuh1*, Dora Mbanya2 and Claude Tayou Tagny3

1General Medicine, Faculty of Medicine and Biomedical Sciences Yaounde, Cameroon
2Hematology, Faculty of Health Sciences Bamenda, Cameroon
3Hematology, Faculty of Medicine and Biomedical Sciences Yaounde, Cameroon

*Corresponding Author: Fonweban Yvonne Ngoikuh, General Medicine, Faculty of Medicine and Biomedical Sciences Yaounde, Cameroon.

Received: December 02, 2019; Published: January 03, 2020


Introduction: The human immunodeficiency virus (HIV) and human T-lymphotropic virus (HTLV) have gained global concern in the last decades. Infection with HIV is a major public health problem worldwide responsible for diverse clinical manifestations with increased morbidity and mortality in infected individuals. The emergence of several pathogens like HTLV in HIV carriers has complicated the management of the coinfection as there is neither a cure nor effective treatment for HTLV infection. The impact of co-infection of these two viruses on the immune system and disease progression remains unclarified. These retroviruses share similar routes of transmission and as a result co-infection is not rare in areas where they both co-exist. Cameroon which is an endemic zone for HTLV, has one of the highest HIV prevalence rates in Central Africa. However, information on HIV and HTLV co-infection in Cameroon is sparse. As a result, we carried out this study in a border area of the South Region of Cameroon.

Objectives: This study was carried out with the main aim to determine the prevalence of HIV and HTLV co-infection in the Abang Minko’o area of the South Region of Cameroon.

Methods: From October 2014 to May 2015, we carried out a cross-sectional analytic and descriptive study, in which pre-structured questionnaires were completed by the principal investigator and blood samples were collected from adults in the Abang Minko’o area of the South Region of Cameroon. Abang Minko’o is a border area located at about 220 km from the capital city, Yaounde and 1.5 km away from the border between Cameroon and Gabon. It is a commercial area with an international market, ‘Marché Mondial’ which attracts people from different regions in Cameroon, Gabon, Equatorial Guinea, Sao Tome and Principe, and Congo, and who all interact freely there. Hence, sexual promiscuity is high in this area. The blood specimens collected were screened for HIV using two rapid tests, Determine® HIV 1/2 test and ImmunoComb® II HIV 1 and 2 BiSpot test on the field site in Abang Minko’o, and the samples were transported to Yaounde, where in the Haematology Laboratory of the Yaounde University Teaching Hospital, further screened using an Enzyme-Linked ImmunoSorbent assay, Murex HIV Ag/Ab Combo. The samples were also screened for HTLV using the rapid test ImmunoComb® II HTLV 1 and 2 assay, which does not distinguish between the two types. Data was entered using Microsoft Excel 2013 and analyzed using SPSS version 20.0. Where appropriate, the Chi Square test was used to establish risk ratio (RR), confidence intervals (CI) and p-values. All p-values less than 0.05 were considered statistically significant.

Results: Out of 157 participants’ blood specimens analyzed, 10 were seropositive for HIV infection giving a prevalence rate of 6.4%. The prevalence was highest in the age group of 50-59 years (25% that is 3 participants out of 12) followed by in young adults of 30-39 years (9.5% that is 4 participants out of 42). Females were more infected (7.1%) than males (5.7%). The natives from Abang Minko’o called the Ntoumous, had the highest HIV prevalence rate (8.4%). Infection with HTLV 1 and 2 was found in 35 out of the 157 participants included in our study, giving a prevalence rate of 22.3%. The prevalence of HTLV generally increased with age and was highest amongst the age group 50-59 years (41.7%). Males were more infected (26.4%) than females (17.1%) with a sex ratio of 1.92.Co-infection with HIV and HTLV 1 and 2 was found in 4 out of the 157 participants, giving a prevalence rate of co-infection of 2.5%. The prevalence of HTLV 1 and 2 in HIV-1 positive participants was 40% which was 16 times more when compared to the co-infection rate in the general population. All the co-infected participants were natives from Abang Minko’o, the Ntoumous with males more infected than females (sex ratio 3:1). The trends of HIV and HTLV 1 and 2 infections in seropositive participants for each virus were almost similar.

  Amongst the risk factors associated with sexual behaviour and HIV transmission identified, sex-money exchange (prostitution) and a history of sexually transmitted infections (STIs) were significantly associated with HIV infection. Those practising sex-money exchange were more infected (10.5%; p = 0.039) and almost 2 times more at risk of HIV infection (RR 1.729; p = 0.039), and those who did so regularly were 4 times more exposed (RR 4.450; p = 0.075) even though this difference was not statistically significant. Participants with a history of STIs were more infected (12%; p = 0.048) and were 2 times more exposed to HIV infection (RR 2.005; p = 0.048). However, some other risk factors identified though not statistically significant, exposed more to HIV infection like alcohol consumption (RR 1.097; p = 0.786), cigarette consumption (RR 1.838; p = 0.381), visitation of night clubs or bars (RR 1.114; p = 0.754) with 2 times more exposure in regular visitors (RR 2.066; p = 0.506), sexual activity (RR 1.035; p = 0.553), age at first sex ˂16 years (RR 1.216; p = 0.260), having more than one sexual partner in the last 12 months (RR 1.421; p = 0.206), cheating on partner (RR 1.452; p = 0.124), homosexuality (RR 3.675; p = 0.205) and having a history of induced abortion or unwanted pregnancy (RR 1.405; p = 0.313). The use of condoms was found to be protective against HIV infection (RR 0.808; p = 0.455) and consistent use was even more protective (RR 0.000; p = 0.554) than inconsistent use (RR 0.854; p = 0.554).

Conclusion: We can conclude that the prevalence of HIV and HTLV 1 and 2 are high in Abang Minko’o. Co-infection of HIV and HTLV 1 and 2 is not rare. The prevalence of HTLV 1 and 2 in HIV-1 infection is high. Sexual behaviours are less tempered by social norms and values in this border area. The Abang Minko’o population constitutes a potentially vulnerable group for HIV and HTLV transmission. We can conclude that the prevalence of HIV and HTLV 1 and 2 are high in Abang Minko’o. Co-infection of HIV and HTLV 1 and 2 is not rare. The prevalence of HTLV 1 and 2 in HIV-1 infection is high. Sexual behaviours are less tempered by social norms and values in this border area. The Abang Minko’o population constitutes a potentially vulnerable group for HIV and HTLV transmission.

Recommendations: The Ministry of Public Health should emphasize on the need for regular and consistent use of condoms especially in mobile populations as a tool to prevent HIV transmission and co-infections, and also evaluate the cost-effectiveness of systematic screening for HTLV 1 and 2 on all blood donors before transfusion of collected samples in order to prevent transmission of the virus by blood transfusion through complementary studies on HTLV nationwide.

Keywords: Retroviruses; HIV; HTLV; Co-Infection; Prevalence; Risk Factors; Sexual Behavior; Border Area



  1. WHO1. “HIV department. Core epidemiological slides”. HIV/AIDS estimates (2014).
  2. UNAIDSUNAIDS. “Global Reports - UNAIDS report on the global AIDS epidemic 2013” (UNAIDS, Geneva, 2013). Geneva: UNAIDS (2013).
  3. Agyingi LM., et al. The evolution of HIV-1 group M genetic variability in Southern Cameroon is characterized by several emerging recombinant forms of CRF02_AG and viruses (2014).
  4. Lihana RW., et al. “Update on HIV-1 diversity in Africa: a decade in review.” AIDS Reviews (2012):14.3 83-100.
  5. Ndembi N., et al. “High frequency of HIV-1 dual infections in Cameroon, West Central Africa”. Journal of Acquired Immune Deficiency Syndromes 57.2 (2011): 25-27.
  6. Faria NR., et al. “Phylodynamics of the HIV-1 CRF02_AG clade in Cameroon”. Infection, Genetics and Evolution 12.2 (2012): 453-460.
  7. Vallari A., et al. “Confirmation of putative HIV-1 group P in Cameroon”. Journal of Virology 85.3 (2011): 1403-1407.
  8. Brennan CA., et al. “The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to 2004”. Journal of Acquired Immune Deficiency Syndromes 49.4 (2008): 432-439.
  9. Ssemwanga D., et al. “Update on HIV-1 Acquired and Transmitted Drug Resistance in Africa”. AIDS Reviews 27 (2014): 3-20.
  10. Nkengasong JN., et al. “HIV antiretroviral drug resistance in Africa”. AIDS Reviews 6.1 (2004): 4-12.
  11. Marina Lobato Martins., et al. “. In Tech (2012). 
  12. Edlich RF., et al. “Global epidemic of human T-cell lymphotrophic virus type-I (HTLV-I): an update”. Journal of Long-Term Effects of Medical Implants 13.2 (2003): 127-140.
  13. Mota A., et al. “A case-control study of HTLV-infection among blood donors in Salvador, Bahia, Brazil- Associated risk factors and trend towards declining prevalence”. Revista Brasileira de Hematologia e Hemoterapia 28.2 (2006):120-126.
  14. Zheng H., et al. “Emergence of novel and highly divergent HTVL-3 in a primate hunter in Cameroon”. Virology 41.2 (2010):137-145.
  15. Mahieux R and A Gessain. “HTLV-3/STLV-3 and HTLV-4 Viruses: Discovery, Epidemiology, Serology and Molecular Aspects”. Viruses 3.7 (2011): 1074-1090.
  16. Filippone C., et al. “A New and Frequent Human T-Cell Leukemia Virus Indeterminate Western Blot Pattern: Epidemiological Determinants and PCR Results in Central African Inhabitants”. Journal of Clinical Microbiology 50.5 (2012): 1663-1672.
  17. Verdonck K., et al. “Human T-lymphotropic virus 1: recent knowledge about an ancient infection”. The Lancet Infectious Diseases 7.4 (2007): 266-281.
  18. Brites C., et al. “Co-infection with HTLV-1 is associated with a shorter survival time for HIV-1-infected patients in Bahia, Brazil”. AIDS 15.15 (2001): 2053-2055.
  19. Beilke MA. “Retroviral coinfections: HIV and HTLV: taking stock of more than a quarter century of research”. AIDS Research and Human Retroviruses 28.2 (2012):139-147.
  20. Ndumbe PM., et al. “Infections among pygmies in the Eastern Province of Cameroon”. Medical Microbiology and Immunology 182.6 (1993): 281-284.
  21. Mbanya DN., et al. “Serological findings amongst first-time blood donors in Yaoundé, Cameroon: is safe donation a reality or a myth?” Transfusion Medicine 13.5 (2003): 267-273. 
  22. Edlich RF., et al. “Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I)”. Journal of Emergency Medicine 18.1 (2000): 109-119.
  23. Roy U., et al. “Upregulation of HTLV-1 and HTLV-2 expression by HIV-1 in vitro”. Journal of Medical Virology 80.3 (2008): 494-500.
  24. Beilke MA., et al. “Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection”. Clinical Infectious Diseases 44.9 (2007):1229-1234.
  25. Casseb J., et al. “T CD4+ cells count among patients co-infected with human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type 1 (HTLV-1): high prevalence of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM)”. Revista do Instituto de Medicina Tropical de São Paulo (2007): 231-233.
  26. Pomier C., et al. “Antiretroviral therapy (ART) promotes an inflammatory pattern of HTLV-1 replication in HIV-1/HTLV-1 coinfected individuals”. Journal of General Virology 94.4 (2013): 735-737.
  27. Casoli C., et al. “Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression”. AIDS Reviews 9.3 (2007): 140-149.
  28. Scapellato PG., et al. “CD4 cell count among HIV-infected patients with an AIDS-defining disease: higher count in patients coinfected than in those not coinfected with human T-cell lymphotropic virus type I”. Journal of Acquired Immune Deficiency Syndromes 33.2 (2003): 279-280.
  29. Bartholomew C., et al. “Progression to AIDS in homosexual men co-infected with HIV and HTLV-I in Trinidad”. Lancet 2.8573 (1987):1469.
  30. Brites C., et al. “HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression”. AIDS Reviews 11.1 (2009): 8-16.
  31. Page JB., et al. “HTLV-I/II seropositivity and death from AIDS among HIV-1 seropositive intravenous drug users”. Lancet 335.8703 (1990):1439-1441.
  32. Cameroon. Literacy rate in Cameroon (2010). 
  33. Collins JA., et al. “Almenara Hospital AIDS Working Group. HTLV-I infection is not associated with a higher risk of death in Peruvian HIV-infected patients”. Revista do Instituto de Medicina Tropical de São Paulo 51.4 (2009): 197-201. 
  34. Holmgren B., et al. “Mortality associated with HIV-1, HIV-2, and HTLV-I single and dual infections in a middle-aged and older population in Guinea-Bissau”. Retrovirology 4 (2007): 85.
  35. DHS. “Demographic and Health Survey report”. Yaounde, Cameroon. Yaounde (2011).
  36. Dodson B and J Crush. “'Mobile 'Deathlihoods': Migration and HIV/AIDS in Africa', Paper for the UNAIDS Project 'AIDS in Africa; Scenarios for the Future'.” AIDS in Africa; Scenarios for the Future (2003).
  37. Proietti FA., et al. “Global epidemiology of HTLV-I infection and associated diseases”. Nature Publishing Group, Oncogene 24 (2005): 6058-6068.
  38. Regis C., et al. “Onset of opportunistic Infections in patients co-infected by HTLV-1 and HIV-1, with high CD4+ cells count”. The Brazilian Journal of Infectious Diseases 13.4 (2009): 311-313.
  39. Crush Dodson B. Mobile 'Deathlihoods': Migration and HIV/AIDS in Africa', Paper for the UNAIDS Project 'AIDS in Africa; Scenarios for the Future” (2003).
  40. WHO2. “Alcohol Use and Sexual Risk Behaviour: A Cross-Cultural Study in Eight Countries,”World Health Organization, Geneva, Switzerland WHO (2005).
  41. HEART. “Introduction, history and medical aspects of HIV”. In: Medical, (2011).
  42. Steele CM and RA Josephs. ““Alcohol myopia: its prized and dangerous effects”. American Psychologist 45.8 (1990): 921-933.


Citation: Fonweban Yvonne Ngoikuh., et al. “HIV and HTLV Co-Infection in Abang Minko’o Area of the South Region of Cameroon". Acta Scientific Medical Sciences 4.2 (2020): 12-31.


Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US